// App-Quantinova.ai

P410 : Extraintestinal manifestations and quality of life in patients with ulcerative colitis: 1-year data from ICONIC

Researchers

Presenter

  • S Ghosh

Principal Investigators

  • F Casellas

  • C OShea

  • M Leonard

  • J Petersson

  • L Peyrin-Biroulet

Medical Centers

  • University of Birmingham, Birmingham, United Kingdom

  • Crohn-Colitis Care Unit UACC, Hospital Universitari Vall -Hebron, Spain

  • AbbVie Limited,Dublin,Ireland

  • AbbVie Inc., North Chicago, Illinois, United States

  • University of Lorraine, Nancy, France

Locations

  • United Kingdom

  • Spain

  • Ireland

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Gastroenterology (GU)

  • Central Nervous System (CNS)

  • Infectious Diseases (ID)

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Ulcerative colitis

  • Depression

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A